Seroquel
Product Images NDC 69189-0484

5 FDA label images from Avera Mckennan Hospital · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Seroquel (NDC 69189-0484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Xr 300 mg Tablet (6918904841)

Quetiapine Xr 300 mg Tablet (6918904841)
SEROQUEL XR 300 MG tablet packaging label displaying the active ingredient Quetiapine XR 300 mg. The label includes manufacturing details with AstraZeneca as the manufacturer, lot numbers, and an expiration date of 01/12/2017. It shows the product NDC 69189-0484 and is labeled by Avera McKennan, Sioux Falls, SD.*
FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram showing the active ingredient components from SEROQUEL XR by Avera McKennan Hospital. The image depicts a molecular structure with multiple ring systems and functional groups, alongside a smaller molecular ion, representing the compound's chemical form.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Image 02)

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Image 02)
A line graph showing the proportion of patients with relapse (%) over time (months). Two curves are compared: PLA (dashed line) and QTP XR (solid line). The graph illustrates relapse proportion increasing more rapidly in the PLA group compared to the QTP XR group during a 7-month period.*
FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Image 03)

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Image 03)
A line graph showing the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. Two lines compare groups labeled QTP+ LI/VAL and PLA+ LI/VAL, with their proportions of relapse increasing at different rates over the study period.*
FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Image 04)

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Image 04)
A line graph showing the proportion of patients with relapse over time in weeks for two groups: QTP+LIVAL and PLA+LIVAL. The y-axis represents the percentage of patients with relapse from 0 to 100%, and the x-axis shows time from 0 to 100 weeks. The graph compares relapse rates between the two treatments over the study period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.